Cine-magnetic Resonance Imaging (MRI) Detecting Intra Abdominal Adhesions
Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Apr 15, 2009
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of MRI called functional cine-MRI to see how well it can detect and map tissue adhesions inside the abdomen. Adhesions are bands of scar tissue that can form after surgery and may lead to serious problems, like chronic pain or bowel blockages. The goal of the trial is to find out how accurately this MRI technique can identify these adhesions in patients who need to have more surgery.
To participate in this study, you need to be between the ages of 65 and 74 and have a significant scar from a previous abdominal surgery that is at least 10 centimeters long. You also need to be able to tolerate an MRI, so if you have severe claustrophobia or any condition that prevents you from having an MRI, you won't be able to join. If you decide to participate, you can expect to undergo an MRI scan that will help researchers understand if this new imaging method can improve the way doctors detect adhesions, potentially leading to safer and more effective surgeries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a median abdominal scar due to a previous open abdominal surgical procedures with a length of at least 10 cm and have given written consent.
- Exclusion Criteria:
- • Severe claustrophobia.
- • No MRI allowed
About Radboud University Medical Center
Radboud University Medical Center is a leading academic medical institution located in Nijmegen, the Netherlands, dedicated to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, Radboud UMC leverages its multidisciplinary expertise to conduct high-quality research that aims to improve patient outcomes and enhance medical knowledge. The center is committed to ethical standards and regulatory compliance, fostering collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical applications. With a focus on personalized medicine and cutting-edge technologies, Radboud University Medical Center plays a pivotal role in shaping the future of healthcare through its rigorous clinical trial initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eindhoven, Netherlands
'S Hertogenbosch, Netherlands
Arnhem, Gelderland, Netherlands
Nijmegen, Gelderland, Netherlands
Apeldoorn, Netherlands
Patients applied
Trial Officials
Harry van Goor, MD, PhD
Study Director
Radboud University Nijmegen Medical Center
Richard PG ten Broek
Principal Investigator
Radboud University Nijmegen Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials